By the numbers: The big vaccine rollout

Government scrambles to rethink strategy after analysis of shortcomings in AstraZeneca shot

It is absurd that there should even be a question about whether the government can afford a vaccine programme; absurd, too, that it would consider a ...

Developing and emerging markets are, by and large, doing far less well